These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27515268)

  • 21. Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells.
    Okamoto M; Soeda T; Asamura A; Tanaka K; Watanabe K; Ikeda T
    J Vet Med Sci; 2019 Mar; 81(3):397-400. PubMed ID: 30674742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
    Izadi P; Mehrdad N; Foruzandeh F; Reza NM
    Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens.
    de Cremoux P; Tran-Perennou C; Brockdorff BL; Boudou E; Brünner N; Magdelénat H; Lykkesfeldt AE
    Endocr Relat Cancer; 2003 Sep; 10(3):409-18. PubMed ID: 14503918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.
    Rokicki J; Das PM; Giltnane JM; Wansbury O; Rimm DL; Howard BA; Jones FE
    Mol Cancer; 2010 Jun; 9():150. PubMed ID: 20550710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
    Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
    J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
    Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
    J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
    Tamimi RM; Baer HJ; Marotti J; Galan M; Galaburda L; Fu Y; Deitz AC; Connolly JL; Schnitt SJ; Colditz GA; Collins LC
    Breast Cancer Res; 2008; 10(4):R67. PubMed ID: 18681955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
    Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
    Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inner nuclear membrane localization of epidermal growth factor receptor (EGFR) in spontaneous canine model of invasive micropapillary carcinoma of the mammary gland.
    Rodrigues MA; Gamba CO; Faria JA; Ferreira Ê; Goes AM; Gomes DA; Cassali GD
    Pathol Res Pract; 2016 Apr; 212(4):340-4. PubMed ID: 26944829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas.
    Maniscalco L; Millán Y; Iussich S; Denina M; Sánchez-Céspedes R; Gattino F; Biolatti B; Sasaki N; Nakagawa T; Di Renzo MF; de Las Mulas JM; De Maria R
    BMC Vet Res; 2013 Apr; 9():80. PubMed ID: 23587222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
    Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
    BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
    Mainenti M; Rasotto R; Carnier P; Zappulli V
    Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
    Chen C; Yuan JP; Wei W; Tu Y; Yao F; Yang XQ; Sun JZ; Sun SR; Li Y
    Int J Nanomedicine; 2014; 9():1039-48. PubMed ID: 24591826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
    Zhang C; Mori M; Gao S; Li A; Hoshino I; Aupperlee MD; Haslam SZ; Xiao H
    Cancer Res; 2010 Dec; 70(24):10224-33. PubMed ID: 21159643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study.
    Terzaghi L; Banco B; Groppetti D; Dall'Acqua PC; Giudice C; Pecile A; Grieco V; Lodde V; Luciano AM
    Res Vet Sci; 2020 Oct; 132():101-107. PubMed ID: 32544632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland.
    Lantinga-van Leeuwen IS; van Garderen E; Rutteman GR; Mol JA
    J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):219-28. PubMed ID: 11282275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.